VOGLIGOLD G3 M0.3 is a powerful combination medication formulated to manage Type 2 Diabetes Mellitus effectively. By combining Voglibose, Glimepiride, and Metformin Hydrochloride, it offers a multi-faceted approach to controlling blood sugar levels and preventing diabetes-related complications.

How Does It Work?

• Voglibose: An alpha-glucosidase inhibitor that delays the absorption of carbohydrates in the intestine, reducing postprandial blood glucose spikes.
• Glimepiride: A sulfonylurea that stimulates the pancreas to release more insulin, thereby lowering blood sugar.
• Metformin Hydrochloride: A biguanide that decreases glucose production in the liver and improves insulin sensitivity, enhancing glucose uptake by cells.

Uses

• Effective in managing blood sugar levels in patients with Type 2 Diabetes.
• Helps reduce the risk of long-term diabetic complications.
• Can be used as part of a comprehensive treatment plan including diet and exercise.

What is VOGLIGOLD G3 M0.3?

VOGLIGOLD G3 M0.3 is an oral antidiabetic medication combining 0.3 mg of Voglibose, 3 mg of Glimepiride, and 500 mg of Metformin Hydrochloride. This combination targets multiple pathways to control blood glucose levels.

Side Effects

• Common: Gastrointestinal discomfort, hypoglycemia, dizziness.
• Less common: Allergic reactions, lactic acidosis (rare but serious with Metformin).

Safety Information

• Not recommended for patients with severe renal or hepatic impairment.
• Regular monitoring of blood glucose levels is essential.
• Maintain a balanced diet and regular exercise routine.
• Consult a healthcare provider before starting or adjusting the medication.
• Ensure adequate hydration to prevent dehydration and related complications.

If You Need More Information About  VOGLIGOLD G3 M0.3  Click here